FDA chief vows mifepristone probe
Source: the hill
Alejandra OConnell-Domenech, Nathaniel Weixel and Joseph Choi - 06/03/25 6:57 PM ET
........
Food and Drug Administration (FDA) head Marty Makary vowed to review the abortion drug mifepristone after previously saying he had no plans to take action on the drug.
As with all drugs, FDA continues to closely monitor the postmarketing safety data on mifepristone for the medical termination of an early pregnancy, Makary wrote in a letter to Sen. Josh Hawley (R-Mo.).
........................
Hawley has repeatedly tried to pressure the Trump administration into reviewing mifepristones safety. In April, the senator urged Makary to review new data released on the abortion medication and to restore critical safeguards on its use.
Health and Human Services (HHS) Secretary Robert F. Kennedy Jr. has also pushed for a review of the drug. A spokesperson for HHS told The Hill Kennedy recently urged Makary to review new data on the drug as well.
The new data Hawley referred to comes from a report released in April from the
conservative think tank The Ethics and Public Policy Center.................
............................
Read more: https://thehill.com/newsletters/health-care/5331591-fda-chief-vows-mifepristone-probe/
I think most of us knew the Repugs would be coming after mifepristone
I am surprised they did not do it on day ONE!